logo
Hemisphere Energy Announces 2024 Fourth Quarter and Year-End Financial and Operating Results

Hemisphere Energy Announces 2024 Fourth Quarter and Year-End Financial and Operating Results

Vancouver, British Columbia--(Newsfile Corp. - April 17, 2025) - Hemisphere Energy Corporation (TSXV: HME) (OTCQX: HMENF) ('Hemisphere' or the 'Company') is pleased to provide its financial and operating results for the fourth quarter and year ended December 31, 2024.
2024 Highlights
Note:
(1)Non-IFRS financial measure that is not a standardized financial measure under International Financial Reporting Standards ('IFRS') and may not be comparable to similar financial measures disclosed by other issuers. Refer to 'Non-IFRS and Other Financial Measures' section below.
Financial and Operating Summary
Selected financial and operational highlights should be read in conjunction with Hemisphere's audited consolidated financial statements and related Management's Discussion and Analysis for the year ended December 31, 2024. These reports, including the Company's Annual Information Form for the year ended December 31, 2024, are available on SEDAR+ at www.sedarplus.ca and on Hemisphere's website at www.hemisphereenergy.ca. All amounts are expressed in Canadian dollars unless otherwise noted.
[This table cannot be displayed. Please visit the source.]
Note:
(1)Non-IFRS financial measure that is not a standardized financial measure under IFRS Accounting Standards ('IFRS') and may not be comparable to similar financial measures disclosed by other issuers. Refer to 'Non-IFRS and Other Financial Measures' section of the MD&A.
[This table cannot be displayed. Please visit the source.]
Operations Update and Outlook
2024 marked another strong year for Hemisphere, with record production levels of over 3,400 boe/d (99% heavy oil), near record AFF of $45.8 million, record shareholder returns of over $21 million ($0.21/share) through dividends and share buybacks, and an increase in its net cash position at year end to $6.4 million. The Company's first quarter 2025 field estimated production has since grown to 3,800 boe/d (99% heavy oil) through continued success of its polymer floods, despite no new wells being drilled since the third quarter of 2024.
Given the strong financial position and performance outlook of the Company, Hemisphere recently announced a special dividend of C$0.03 per common share to be paid on April 28, 2025 to shareholders of record on April 17, 2025. In 2024, Hemisphere's total dividend payments to shareholders of C$0.16 per common share included two special dividends of C$0.03 per common share (in each of July and November), in addition to the base annual dividend of C$0.10 per common share. These special dividends are an important part of Hemisphere's overall shareholder return model.
As seen over the first two weeks of April, pricing outlook for the oil market is experiencing significant volatility influenced by geopolitical developments, supply-demand dynamics, and trade tensions. Hemisphere's 2025 budget is extremely flexible with minimal capital spending planned until summer. The Company's robust balance sheet, ultra-low decline assets, and limited sustaining capital requirements for 2025 position Hemisphere well to withstand these economic headwinds.
About Hemisphere Energy Corporation
Hemisphere is a dividend-paying Canadian oil company focused on maximizing value-per-share growth with the sustainable development of its high netback, low decline conventional heavy oil assets through polymer flood enhanced oil recovery methods. Hemisphere trades on the TSX Venture Exchange as a Tier 1 issuer under the symbol 'HME' and on the OTCQX Venture Marketplace under the symbol 'HMENF'.
For further information, please visit the Company's website at www.hemisphereenergy.ca to view its corporate presentation or contact:
Don Simmons, President & Chief Executive Officer
Telephone: (604) 685-9255
Email: [email protected]
Website: www.hemisphereenergy.ca
Forward-Looking Statements
Certain statements included in this news release constitute forward-looking statements or forward-looking information (collectively, 'forward-looking statements') within the meaning of applicable securities legislation. Forward-Looking statements are typically identified by words such as 'anticipate', 'continue', 'estimate', 'expect', 'forecast', 'may', 'will', 'project', 'could', 'plan', 'intend', 'should', 'believe', 'outlook', 'potential', 'target' and similar words suggesting future events or future performance. In particular, but without limiting the generality of the foregoing, this news release includes forward-looking statements that a special dividend will be paid to shareholders on April 28, 2025 to shareholders of record on April 17, 2025; Hemisphere's intention to have minimal capital spending until summer; and the Company's view that its robust balance sheet, ultra-low decline assets, and limited sustaining capital requirements for 2025 position Hemisphere well to withstand economic headwinds.
Forward‐Looking statements are based on a number of material factors, expectations or assumptions of Hemisphere which have been used to develop such statements and information, but which may prove to be incorrect. Although Hemisphere believes that the expectations reflected in such forward‐looking statements or information are reasonable, undue reliance should not be placed on forward‐looking statements because Hemisphere can give no assurance that such expectations will prove to be correct. In addition to other factors and assumptions which may be identified herein, assumptions have been made regarding, among other things: the current and go-forward oil price environment; that Hemisphere will continue to conduct its operations in a manner consistent with past operations; that results from drilling and development activities are consistent with past operations; current budgets; the quality of the reservoirs in which Hemisphere operates and continued performance from existing wells; the continued and timely development of infrastructure in areas of new production; the accuracy of the estimates of Hemisphere's reserve volumes; certain commodity price and other cost assumptions; continued availability of debt and equity financing and cash flow to fund Hemisphere's current and future plans and expenditures; the impact of increasing competition; the general stability of the economic and political environment in which Hemisphere operates; the general continuance of current industry conditions; the timely receipt of any required regulatory approvals; the ability of Hemisphere to obtain qualified staff, equipment and services in a timely and cost efficient manner; drilling results; the ability of the operator of the projects in which Hemisphere has an interest in to operate the field in a safe, efficient and effective manner; the ability of Hemisphere to obtain financing on acceptable terms; field production rates and decline rates; the ability to replace and expand oil and natural gas reserves through acquisition, development and exploration; the timing and cost of pipeline, storage and facility construction and expansion and the ability of Hemisphere to secure adequate product transportation; future commodity prices; currency, exchange and interest rates; regulatory framework regarding royalties, taxes and environmental matters in the jurisdictions in which Hemisphere operates; trade and tariff matters, including the impacts on costs and supply chains; and the ability of Hemisphere to successfully market its oil and natural gas products.
The forward‐looking statements included in this news release are not guarantees of future performance and should not be unduly relied upon. Such information and statements, including the assumptions made in respect thereof, involve known and unknown risks, uncertainties and other factors that may cause actual results or events to defer materially from those anticipated in such forward‐looking statements including, without limitation: changes in commodity prices; changes in the demand for or supply of Hemisphere's products, changes in Hemisphere's budget, the early stage of development of some of the evaluated areas and zones; unanticipated operating results or production declines; changes in tax or environmental laws, royalty rates or other regulatory matters; changes in development plans of Hemisphere or by third party operators of Hemisphere's properties, increased debt levels or debt service requirements; inaccurate estimation of Hemisphere's oil and gas reserve volumes; limited, unfavourable or a lack of access to capital markets; increased costs; a lack of adequate insurance coverage; the impact of competitors; and certain other risks detailed from time‐to‐time in Hemisphere's public disclosure documents, (including, without limitation, those risks identified in this news release and in Hemisphere's Annual Information Form).
The forward‐looking statements contained in this news release speak only as of the date of this news release, and Hemisphere does not assume any obligation to publicly update or revise any of the included forward‐looking statements, whether as a result of new information, future events or otherwise, except as may be required by applicable securities laws.
This MD&A contains the terms adjusted funds flow from operations, free funds flow, operating field netback and operating netback, capital expenditures and working capital/net debt, which are considered 'non-IFRS financial measures' and any of these measures calculated on a per boe basis, which are considered 'non-IFRS financial ratios'. These terms do not have a standardized meaning prescribed by IFRS. Accordingly, the Company's use of these terms may not be comparable to similarly defined measures presented by other companies. Investors are cautioned that these measures should not be construed as an alternative to net income (loss) or cashflow from operations determined in accordance with IFRS and these measures should not be considered more meaningful than IFRS measures in evaluating the Company's performance.
a)Adjusted funds flow from operations 'AFF' (Non-IFRS Financial Measure and Ratio if calculated on a per boe basis): The Company considers AFF to be a key measure that indicates the Company's ability to generate the funds necessary to support future growth through capital investment and to repay any debt. AFF is a measure that represents cash flow generated by operating activities, before changes in non-cash working capital and adjusted for tax provision and decommissioning expenditures, and may not be comparable to measures used by other companies. The most directly comparable IFRS measure for AFF is cash provided by operating activities. AFF per share is calculatedusing the same weighted-average number of shares outstanding as in the case of the earnings per share calculation for the period.
A reconciliation of AFF to cash provided by operating activities is presented as follows:
[This table cannot be displayed. Please visit the source.]
(1)Provision for income taxes deferred under new corporate partnership structure effective as of January 2, 2024.
b)Free funds flow ('FFF') (Non-IFRS Financial Measures): Calculated by taking adjusted funds flow and subtracting capital expenditures, excluding acquisitions and dispositions. Management believes that free funds flow provides a useful measure to determine Hemisphere's ability to improve returns and to manage the long-term value of the business.
[This table cannot be displayed. Please visit the source.]
c)Capital Expenditures (Non-IFRS Financial Measure): Management uses the term 'capital expenditures' as a measure of capital investment in exploration and production assets, and such spending is compared to the Company's annual budgeted capital expenditures. The most directly comparable IFRS measure for capital expenditures is cash flow used in investing activities. A summary of the reconciliation of cash flow used in investing activities to capital expenditures is set forth below:
[This table cannot be displayed. Please visit the source.]
d)Operating field netback (Non-IFRS Financial Measure and Ratio if calculated on a per boe basis): A benchmark used in the oil and natural gas industry and a key indicator of profitability relative to current commodity prices. Operating field netback is calculated as oil and gas sales, less royalties, operating expenses, and transportation costs on an absolute and per barrel of oil equivalent basis. These terms should not be considered an alternative to, or more meaningful than, cash flow from operating activities or net income or loss as determined in accordance with IFRS as an indicator of the Company's performance.
e)Operating netback (Non-IFRS Financial Measure and Ratio if calculated on a per boe basis): Calculated as the operating field netback plus the Company's realized gain (loss) on derivative financial instruments on an absolute and per barrel of oil equivalent basis.
f)Working capital/Net debt (Non-IFRS Financial Measure): Closely monitored by the Company to ensure that its capital structure is maintained by a strong balance sheet to fund the future growth of the Company. Working capital/net debt is used in this document in the context of liquidity and is calculated as the total of the Company's current assets, less current liabilities, excluding derivative financial instruments, decommissioning obligations, and lease liabilities, adjusted for tax provision and including any bank debt. There is no IFRS measure that is reasonably comparable to working capital/net debt.
The following table outlines the Company calculation of net debt:
[This table cannot be displayed. Please visit the source.]
Notes:
(1)Excluding fair value of financial instruments, decommissioning obligations, and lease liabilities.
(2)Provision for income taxes deferred under new corporate partnership structure effective as of January 2, 2024.
g)Supplementary Financial Measures and Ratios
'Adjusted Funds Flow from operations per basic share' is comprised of funds from operations divided by basic weighted average common shares.
'Adjusted Funds Flow from operations per diluted share' is comprised of funds from operations divided by diluted weighted average common shares.
'Annual Free Funds Flow' is comprised of free funds flow from the current three-month period multiplied by four.
'Operating expense per boe' is comprised of operating expense, as determined in accordance with IFRS, divided by the Company's total production.
'Realized heavy oil price' is comprised of heavy crude oil commodity sales from production, as determined in accordance with IFRS, divided by the Company's crude oil production.
'Realized natural gas price' is comprised of natural gas commodity sales from production, as determined in accordance with IFRS, divided by the Company's natural gas production.
'Realized combined price' is comprised of total commodity sales from production, as determined in accordance with IFRS, divided by the Company's total production.
'Royalties per boe' is comprised of royalties, as determined in accordance with IFRS, divided by the Company's total production.
'Transportation costs per boe' is comprised of transportation expenses, as determined in accordance with IFRS, divided by the Company's total production.
The Company has provided additional information on how these measures are calculated in the Management's Discussion and Analysis for the year ended December 31, 2024, which is available under the Company's SEDAR+ profile atwww.sedarplus.ca.
Oil and Gas Advisories
Any references in this news release to initial production rates (including as a result of recent water or polymer flood activities) are useful in confirming the presence of hydrocarbons; however, such rates are not determinative of the rates at which such wells will continue production and decline thereafter and are not necessarily indicative of long-term performance or ultimate recovery. While encouraging, readers are cautioned not to place reliance on such rates in calculating the aggregate production for the Company. Such rates are based on field estimates and may be based on limited data available at this time.
A barrel of oil equivalent ('boe') may be misleading, particularly if used in isolation. A boe conversion ratio of 6 Mcf:1 Bbl is based on an energy equivalency conversion method primarily applicable at the burner tip and does not represent a value equivalency at the wellhead. In addition, given that the value ratio based on the current price of crude oil as compared to natural gas is significantly different from the energy equivalency of 6:1, utilizing a conversion on a 6:1 basis may be misleading as an indication of value.
Definitions and AbbreviationsTo view the source version of this press release, please visit https://www.newsfilecorp.com/release/248893

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

ROSEN, SKILLED INVESTOR COUNSEL, Encourages West Pharmaceutical Services, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action
ROSEN, SKILLED INVESTOR COUNSEL, Encourages West Pharmaceutical Services, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action

Associated Press

time28 minutes ago

  • Associated Press

ROSEN, SKILLED INVESTOR COUNSEL, Encourages West Pharmaceutical Services, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action

New York, New York--(Newsfile Corp. - June 13, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of West Pharmaceutical Services, Inc. (NYSE: WST) between February 16, 2023 and February 12, 2025, both dates inclusive (the 'Class Period'), of the important July 7, 2025 lead plaintiff deadline. SO WHAT: If you purchased West common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the West class action, go to or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 7, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers. DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made false and misleading statements and/or failed to disclose that: (1) despite claiming strong visibility into customer demand and attributing headwinds to temporary COVID-related product destocking, West was in fact experiencing significant and ongoing destocking across its high-margin High-Value Products ('HVP') portfolio; (2) West's SmartDose device, which was purportedly positioned as a high-margin growth product, was highly dilutive to West's profit margins due to operational inefficiencies; (3) these margin pressures created the risk of costly restructuring activities, including West's exit from continuous glucose monitoring ('CGM') contracts with long-standing customers; and (4) as a result of the foregoing, defendants' positive statements about West's business, operations, and prospects were materially false and/or misleading or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages. To join the West class action, go to call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff. Follow us for updates on LinkedIn: on Twitter: or on Facebook: Attorney Advertising. Prior results do not guarantee a similar outcome. ------------------------------- Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected] To view the source version of this press release, please visit

Cipher Pharmaceuticals Announces Results of Annual and Special Meeting of Shareholders
Cipher Pharmaceuticals Announces Results of Annual and Special Meeting of Shareholders

Yahoo

timean hour ago

  • Yahoo

Cipher Pharmaceuticals Announces Results of Annual and Special Meeting of Shareholders

MISSISSAUGA, ON, June 13, 2025 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) ("Cipher" or the "Company") announced that it held its annual and special meeting of shareholders earlier today and that all matters put forward before shareholders for consideration and approval as set out in the Company's management information circular dated May 2, 2025 were approved by the requisite majority of votes cast at the meeting. In particular, shareholders approved the election of all director nominees, the re-approval of RSM Canada LLP as auditor of the Company and the resolution approving the unallocated shares, rights and other entitlements under the Company's share purchase plan. A total of approximately 13 million shares, representing approximately 50.9% of the total shares outstanding were represented in person or by proxy at the meeting. The detailed results of the vote for the election of directors of Cipher is set out below: Nominee Votes For % Votes For Votes Withheld % Votes Withheld Craig Mull 11,476,390 96.15 % 459,043 3.85 % Harold Wolkin 11,475,560 96.15 % 459,873 3.85 % Douglas Deeth 11,864,293 99.40 % 71,140 0.60 % Hubert Walinski 11,806,918 98.92 % 128,515 1.08 % About Cipher Pharmaceuticals Inc. Cipher Pharmaceuticals (TSX:CPH) (OTCQX:CPHRF) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products, mainly in dermatology. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products in Canada, the U.S., and South America. For more information, visit SOURCE Cipher Pharmaceuticals Inc. View original content:

Cegedim : Implementation of the plan to transfer the listing of the Group's shares on Euronext Growth
Cegedim : Implementation of the plan to transfer the listing of the Group's shares on Euronext Growth

Yahoo

timean hour ago

  • Yahoo

Cegedim : Implementation of the plan to transfer the listing of the Group's shares on Euronext Growth

PRESS RELEASE Stock market information Cegedim : Implementation of the plan to transfer the listing of the Group's shares on Euronext Growth Boulogne-Billancourt, June 13 2025 - The Combined General Meeting of shareholders of CEGEDIM S.A. held today, approved, in accordance with the provisions of Article L. 421-14 of the French Commercial Code, the proposed transfer of listing of its shares from the Euronext Paris regulated market (compartment B) to the Euronext Growth Paris multilateral trading facility, and granted full power to the Board of Directors to implement this transfer of listing. The Board of Directors, which also met today following the General Meeting, decided to implement this transfer. In the next few days, the Company will file an application with Euronext Paris for the delisting of its shares from Euronext Paris and their concomitant listing on Euronext Growth. Reasons for the transfer Such a transfer will enable CEGEDIM S.A to improve the share's visibility and attractiveness, placing it among the top 30 market capitalizations on Euronext Growth. As part of this change, the Company will move to a less-regulated market, which entails some regulatory relief, but will continue to maintain the best practices described hereafter. Main consequences of the transfer In accordance with current regulations, CEGEDIM S.A. informs its shareholders of the main possible consequences of such a transfer (non-exhaustive list): Periodic information The Company will publish, within four months of the end of the financial year, an annual report including its annual and consolidated financial statements, a management report and the reports of the statutory auditors. The Company will also publish, within four months of the end of the first half of the year, a half-yearly report including its consolidated half-yearly financial statements and a business report relating to these statements. The half-yearly financial statements no longer have to be audited by the statutory auditors. The Company will continue to publish the four quarterly revenue figures, to apply IFRS standards for the consolidated financial statements and to comply with CSRD requirements for sustainability information, the change in market having no impact on this subject. Lastly, the following information in the management report (including the corporate governance report) will no longer be required:- information relating to the remuneration of corporate officers,- information having an impact in the event of a public offer;- and the content of the corporate governance report will be streamlined. Permanent information The Company will continue to inform the public of any information likely to have a significant impact on the share price (insider information). Regulated information (and in particular insider information) must always be disseminated effectively and in full. The Company will continue to use a professional disseminator. The Company will continue to draw up lists of insiders, and senior executives and managers will continue to make declarations of securities transactions to the AMF. Composition of the Board - Corporate governance The Company will continue to apply the rules on parity on the Board set out in Article L.225-18-1 of the French Commercial Code. These parity rules are also in line with the Company's CSR commitments. The Company will continue to be subject to the legal provisions of articles L.823-19 et seq. of the French Commercial Code concerning audit committees. More generally, the existing committees will be maintained, as the Company does not wish to change its good governance practices. Executive remuneration The Shareholders' Meeting will no longer be required to approve the remuneration policy for corporate officers or to approve the remuneration paid or awarded to corporate officers in respect of the previous financial year. Shareholders' Meetings The press release specifying the terms of availability of the documents submitted to the meeting will no longer be required. The preparatory documents for the meeting and other documents (including the total number of voting rights and shares existing at the date of publication of the prior notice) will no longer be required to be posted online twenty-one days before the date of the Shareholders' Meeting, but on the date of the notice of meeting. The results of votes and the minutes of the Shareholders' Meeting will continue to be posted on the Company's website. Disclosure thresholds - Public offer The protection of minority shareholders, in the event of a change of control, will be ensured on Euronext Growth Paris by the mechanism of a mandatory public offer in the event of crossing, directly or indirectly,alone or in concert, the threshold of 50% of the capital or voting rights. Furthermore, companies listed on Euronext Growth Paris only need to communicate to the market, in terms of changes in shareholding, the crossing of thresholds (upwards or downwards) of 50% and 90% of the capital or voting rights. However, in accordance with legal provisions, the company will remain subject, for a period of 3 years from its delisting from the Euronext Paris market, to the public offer regime and the maintenance of information obligations relating to threshold crossings and declarations of intentions as applicable to companies listed on Euronext Paris. Liquidity of the share As Euronext Growth is a less-regulated market, the transfer to Euronext Growth Paris could result in a change in the liquidity of CEGEDIM S.A. shares, which could differ from the liquidity observed on the regulated Euronext Paris market. The Company confirms that the liquidity contact currently in place will be maintained after the market transfer. The transfer could also lead some investors, favoring shares of issuers listed on a regulated market, to sell their CEGEDIM S.A. shares. After studying the composition of its shareholder base, the Company has identified only a very limited number of funds whose prospectuses exclude the possibility of investing on Euronext Growth. Provisional timetable for the transaction (subject to approval by Euronext) In the coming days, an application will be filed with Euronext Paris for the delisting of Cegedim Group shares from the Euronext regulated market and their concomitant admission to Euronext Growth. Subject to approval by Euronext Paris, the Group expects to be admitted to Euronext Growth Paris in early September 2025. The Cegedim Group will be supported in its plan to transfer to Euronext Growth by TP ICAP Midcap as listing sponsor. About Cegedim:Founded in 1969, Cegedim is an innovative technology and services group in the field of digital data flow management for healthcare ecosystems and B2B, and a business software publisher for healthcare and insurance professionals. Cegedim employs nearly6,700 people in more than 10 countries and generated revenue of over €654 million in 2024. Cegedim SA is listed in Paris (EURONEXT: CGM).To learn more please visit: follow Cegedim on X: @Cegedimgroup, LinkedIn, and Facebook. Aude BalleydierCegedimMedia Relations and Communications ManagerTel.: +33 (0)1 49 09 68 Damien BuffetCegedimHead of Financial CommunicationTel.: +33 (0)7 64 63 55 Céline Pardo Becoming RP AgencyMedia Relations ConsultantTel.: +33 (0)6 52 08 13 66cegedim@ Attachment Cegedim_EuronextGrowthTransfert_postAG_ENGError in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store